TrialAntimicrobial agents and chemotherapy2004

Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.

Robin Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.